{
  "aggregate": {
    "max_possible_score": 14,
    "percent_score": 71.4,
    "star_display": "★★★★",
    "star_rating": 4,
    "total_score": 10
  },
  "company": "Cencora",
  "company_slug": "cencora",
  "evidence_breakdown": {
    "by_type": {
      "NARRATIVE": 16,
      "OPERATIONAL": 85,
      "POLICY": 113
    }
  },
  "pillar_scores": {
    "explainability": {
      "best_evidence_type": null,
      "display_name": "Explainability",
      "evidence_count": 0,
      "findings": null,
      "max_score": 2,
      "path_to_improvement": "Document how explanations are provided to users affected by AI decisions.",
      "relevant_sources": [],
      "score": 0,
      "source_count": 0
    },
    "external_accountability": {
      "best_evidence_type": "OPERATIONAL",
      "display_name": "Public Commitments & External Audits",
      "evidence_count": 30,
      "findings": "Documentation emphasizes vendor oversight, contractual safeguards, and mentions FDA acknowledgment of responsible AI principles. Corporate responsibility reports highlight external accountability through third-party assurance procedures, certifications, and vetting of business partners. The company's proxy statements highlight processes for shareholder feedback, the adoption of compensation recoupment policies, and the Audit Committee's role in managing auditor independence and internal controls.",
      "max_score": 2,
      "path_to_improvement": null,
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_003",
          "source_tier": "company_owned",
          "summary": "This press release on Project ELSA provides evidence for the **external_accountability**, **governance**, **oversight**, **privacy**, and **transparency** pillars. It supports these by emphasizing human-led governance, vendor oversight, contractual safeguards, and a risk-based approach to AI deployment. The document highlights the importance of human oversight, data protection, privacy governance, transparency regarding AI capabilities and limitations, and FDA acknowledgment of these principles as foundational tenets for responsible AI use.",
          "title": "What Project ELSA means for the FDA's approach to AI",
          "url": "https://cencora.com/resources/pharma/what-project-elsa-means-for-the-fdas-approach-to-ai"
        },
        {
          "artifact_type": "system_card",
          "source_id": "src_004",
          "source_tier": "company_owned",
          "summary": "This system card, \"AI-Assistance in TMF Privacy & Data Protection Statement,\" provides evidence for **external_accountability, governance, oversight, privacy, and transparency**. It supports these pillars by describing the AI system's capabilities and use case, its alignment with governance frameworks, and its low-risk classification. Furthermore, the document details privacy safeguards, including Data Protection Impact Assessments (DPIAs) and Records of Processing Activities (RoPA), and mentions human oversight with user override capabilities, alongside operational practices like annual audits and risk reviews.",
          "title": "AI-Assistance in TMF Privacy & Data Protection Statement",
          "url": "https://www.cencora.com/our-capabilities/drug-research-and-clinical-development-support/tmf-software-and-services/ai-privacy-and-data-protection-assurance-statement"
        },
        {
          "artifact_type": "audit_report",
          "source_id": "src_010",
          "source_tier": "company_owned",
          "summary": "This Cencora FY24 Corporate Responsibility Reporting Index provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The report details robust governance structures, including named committees and officers, operational risk assessments, and a Code of Ethics review process, demonstrating strong oversight. It also highlights external accountability through third-party assurance procedures and privacy protections via certifications and vetting of business partners, while AI use cases are mentioned, contributing to transparency.",
          "title": "Cencora FY24 Corporate Responsibility Reporting Index",
          "url": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-reporting-index-v8-remediated.pdf"
        },
        {
          "artifact_type": "sec_filing",
          "source_id": "src_011",
          "source_tier": "third_party",
          "summary": "This Form 10-K filing provides evidence for **governance**, **oversight**, **privacy**, and **external accountability**. It details Cencora's cybersecurity governance structure with CISO/CDIO roles and Board oversight through Audit and Compliance & Risk Committees, supporting **governance** and **oversight**. The report also mentions a vendor risk management program and internal controls over financial reporting, contributing to **governance** and **external accountability**. Furthermore, the description of a security program and annual reviews by the CISO and third parties supports the **privacy** pillar.",
          "title": "Form 10-K: Cencora, Inc. FY2024",
          "url": "https://s203.q4cdn.com/785768684/files/doc_financials/2024/q4/ba288052-12c4-42c5-84ce-7fb924e30f65.pdf"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_015",
          "source_tier": "third_party",
          "summary": "This Cencora Inc. Definitive Proxy Statement 2026 provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. The document details board and committee structures responsible for risk oversight, including cybersecurity and enterprise risk management, demonstrating robust governance and oversight mechanisms. It also highlights processes for shareholder feedback and the adoption of policies like compensation recoupment, which support external accountability and compliance. Furthermore, the proxy statement touches upon data governance and responsible technology integration, including AI, and mentions privacy considerations within disclosure policies, supporting the privacy pillar.",
          "title": "Cencora Inc. Definitive Proxy Statement 2026",
          "url": "https://stocktitan.net/sec-filings/COR/def-14a-cencora-inc-definitive-proxy-statement-a4215304321a.html"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_016",
          "source_tier": "company_owned",
          "summary": "This company-owned charter, the \"Code of Ethics and Business Conduct,\" provides evidence for **governance**, **external accountability**, and **privacy**. It supports governance through its comprehensive framework for fraud prevention, conflict of interest, and corruption, overseen by a Chief Compliance Officer with established review and approval processes. The charter also demonstrates external accountability by outlining compliance attestations and disciplinary actions, while privacy is addressed through specific reporting mechanisms for privacy incidents.",
          "title": "Code of Ethics and Business Conduct",
          "url": "https://investor.cencora.com/files/doc_downloads/2024/02/English_2023-2024-Code-of-Ethics.pdf"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_020",
          "source_tier": "third_party",
          "summary": "This proxy statement provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. It details mechanisms for board and committee oversight of enterprise risk management, financial reporting, and compliance, supporting governance and oversight. The document also highlights the role of the Audit Committee in managing auditor independence and internal controls, which demonstrates external accountability. Furthermore, it mentions senior leadership and committees reporting on data governance and security risks, indicating support for the privacy pillar.",
          "title": "2026 Proxy Statement & Shareholder Letter",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/2025/ba55fb6b-8baa-41b5-a467-e2fb086c7c43.pdf"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_022",
          "source_tier": "company_owned",
          "summary": "This press release on AI in pharmacovigilance provides evidence for **external accountability, governance, and oversight**. It highlights the importance of compliance, guardrails, and validation for AI systems, demonstrating a commitment to regulatory expectations and audit-friendliness, which supports external accountability and governance. Furthermore, the emphasis on human-in-the-loop involvement and data standardization before AI adoption points to robust oversight and governance mechanisms.",
          "title": "The growing case for AI to support pharmacovigilance",
          "url": "https://cencora.com/resources/pharma/world-drug-safety-congress-americas-key-takeaways"
        },
        {
          "artifact_type": "other",
          "source_id": "src_024",
          "source_tier": "company_owned",
          "summary": "The \"Quality Management & Compliance Services\" document provides evidence for **external accountability** and **governance**. It supports external accountability by mentioning an \"audit trail\" functionality, which implies a record of actions for external scrutiny. The document also supports governance through references to \"quality assurance systems,\" \"risk management strategies,\" \"remediation plans,\" and \"training programs,\" all of which indicate structured processes and accountability for managing product lifecycle and compliance.",
          "title": "Quality Management & Compliance Services",
          "url": "https://cencora.com/our-capabilities/commercialization-support/quality-management-and-compliance"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_026",
          "source_tier": "company_owned",
          "summary": "This press release provides evidence for the **governance**, **privacy**, and **external_accountability** pillars. It supports **privacy** and **external_accountability** by highlighting commitments to data protection, third-party vetting, and certifications. **Governance** is implied through the mention of corporate responsibility governance structures and program leadership.",
          "title": "Environmental, Social, and Governance Summary Report",
          "url": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-crsummaryreport-fnl.pdf"
        }
      ],
      "score": 2,
      "source_count": 10
    },
    "fairness": {
      "best_evidence_type": "POLICY",
      "display_name": "Fairness & Bias Mitigation",
      "evidence_count": 3,
      "findings": "Press releases acknowledge the need to address bias in digital tools. They also address bias by implying a principled, data-adaptive approach for AI in trials.",
      "max_score": 2,
      "path_to_improvement": "Publish bias testing results, outcome monitoring, or vendor fairness certifications.",
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_007",
          "source_tier": "company_owned",
          "summary": "This company-owned press release discusses the utilization of real-world evidence to support market access decisions, touching upon responsible AI. It provides evidence for **fairness** by acknowledging the need to address bias in digital tools. The press release also supports **governance** by discussing data use and regulatory comfortability, though it focuses on challenges and future needs rather than current execution. Finally, it offers evidence for **transparency** by describing the value of AI-driven insights and data generation capabilities.",
          "title": "Leveraging real-world evidence to support market access decision-making",
          "url": "https://cencora.com/resources/pharma/leveraging-rwe-to-support-market-access-decision-making"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_028",
          "source_tier": "company_owned",
          "summary": "This press release discusses the integration of statistics with AI in the biopharma industry, providing evidence for **governance**, **transparency**, and **fairness**. The document suggests governance over AI's lifecycle and its use in regulatory decisions, as well as transparency in AI's application for pattern discovery and subgroup identification. Furthermore, it addresses bias by implying a principled, data-adaptive approach for AI in trials, supporting the fairness pillar.",
          "title": "RISW 2025 Takeaways: Workshop sheds light on important statistical advances for the biopharma industry",
          "url": "https://www.cencora.com/resources/pharma/2025-risw-workshop-takeaways"
        }
      ],
      "score": 1,
      "source_count": 2
    },
    "governance": {
      "best_evidence_type": "OPERATIONAL",
      "display_name": "Governance & Accountability",
      "evidence_count": 186,
      "findings": "Documentation outlines conditions for data disclosure, rules for data use, and emphasizes human-led governance, vendor oversight, and a risk-based approach to AI deployment. Governance frameworks and cybersecurity structures with CISO/CDIO roles are described, alongside vendor risk management programs and internal controls. The company's governance principles outline asset protection, risk assessment, and financial integrity, with mechanisms for board and committee oversight of enterprise risk management, financial reporting, and compliance.",
      "max_score": 2,
      "path_to_improvement": null,
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_001",
          "source_tier": "company_owned",
          "summary": "This press release discusses the role of AI in pharmaceutical innovation, providing evidence for the **governance**, **privacy**, and **transparency** pillars. It highlights the need for robust data governance frameworks and standards for AI deployment, and addresses data privacy integration challenges. The release also emphasizes the importance of transparency in AI algorithms to avoid biases and ensure accurate outcomes.",
          "title": "Pharma 2025 Insights: Harnessing AI in pharma",
          "url": "https://cencora.com/resources/pharma/insights-from-pharma-2025-harnessing-ai"
        },
        {
          "artifact_type": "privacy_policy",
          "source_id": "src_002",
          "source_tier": "company_owned",
          "summary": "The Cencora Global Privacy Statement provides evidence for the **governance** and **privacy** pillars. This policy document supports governance by outlining conditions for data disclosure and rules for data use, and it supports privacy by detailing safeguards, access controls, protection of personal data, and consent requirements, including specific protections for children's data.",
          "title": "Global Privacy Statement - Cencora",
          "url": "https://cencora.com/global-privacy-statement"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_003",
          "source_tier": "company_owned",
          "summary": "This press release on Project ELSA provides evidence for the **external_accountability**, **governance**, **oversight**, **privacy**, and **transparency** pillars. It supports these by emphasizing human-led governance, vendor oversight, contractual safeguards, and a risk-based approach to AI deployment. The document highlights the importance of human oversight, data protection, privacy governance, transparency regarding AI capabilities and limitations, and FDA acknowledgment of these principles as foundational tenets for responsible AI use.",
          "title": "What Project ELSA means for the FDA's approach to AI",
          "url": "https://cencora.com/resources/pharma/what-project-elsa-means-for-the-fdas-approach-to-ai"
        },
        {
          "artifact_type": "system_card",
          "source_id": "src_004",
          "source_tier": "company_owned",
          "summary": "This system card, \"AI-Assistance in TMF Privacy & Data Protection Statement,\" provides evidence for **external_accountability, governance, oversight, privacy, and transparency**. It supports these pillars by describing the AI system's capabilities and use case, its alignment with governance frameworks, and its low-risk classification. Furthermore, the document details privacy safeguards, including Data Protection Impact Assessments (DPIAs) and Records of Processing Activities (RoPA), and mentions human oversight with user override capabilities, alongside operational practices like annual audits and risk reviews.",
          "title": "AI-Assistance in TMF Privacy & Data Protection Statement",
          "url": "https://www.cencora.com/our-capabilities/drug-research-and-clinical-development-support/tmf-software-and-services/ai-privacy-and-data-protection-assurance-statement"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_005",
          "source_tier": "company_owned",
          "summary": "This press release discusses AI-driven formulary decision-making systems, providing narrative evidence for **governance**, **privacy**, and **transparency**. It mentions AI use cases and decision-makers' recognition, supporting governance, while also touching on security/privacy concerns to support the privacy pillar. The press release also describes the AI's role and company leadership, contributing to the transparency pillar.",
          "title": "Unlock the future of formulary decision-making with AI",
          "url": "https://cencora.com/resources/pharma/unlock-the-future-of-formulary-decision-making-with-ai"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_006",
          "source_tier": "company_owned",
          "summary": "This press release, \"Data governance and AI in pharma,\" provides evidence for the **governance** and **transparency** pillars of responsible AI. It supports governance by discussing data governance strategies and AI compliance, implying a commitment to managing AI responsibly, though without specific execution details. The press release also touches on transparency by mentioning AI use cases and how AI is transforming operations, indicating an aspirational discovery of AI capabilities.",
          "title": "Data governance and AI in pharma",
          "url": "https://cencora.com/resources/pharma/data-governance-and-ai-in-pharma"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_007",
          "source_tier": "company_owned",
          "summary": "This company-owned press release discusses the utilization of real-world evidence to support market access decisions, touching upon responsible AI. It provides evidence for **fairness** by acknowledging the need to address bias in digital tools. The press release also supports **governance** by discussing data use and regulatory comfortability, though it focuses on challenges and future needs rather than current execution. Finally, it offers evidence for **transparency** by describing the value of AI-driven insights and data generation capabilities.",
          "title": "Leveraging real-world evidence to support market access decision-making",
          "url": "https://cencora.com/resources/pharma/leveraging-rwe-to-support-market-access-decision-making"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_008",
          "source_tier": "company_owned",
          "summary": "This press release discusses the application of AI and advanced analytics in pharmacovigilance signal management, providing evidence for **governance** and **transparency**. The document implies governance by mentioning a Head of Pharmacovigilance and their area of responsibility, suggesting oversight of AI applications in this domain. It also supports transparency by describing AI capabilities and use cases in transforming pharmacovigilance, though it focuses on impact rather than specific operational execution.",
          "title": "Harnessing AI and advanced analytics to revolutionize PV signal management",
          "url": "https://cencora.com/resources/pharma/harnessing-ai-and-advanced-analytics-to-revolutionize-pv-signal-management"
        },
        {
          "artifact_type": "audit_report",
          "source_id": "src_010",
          "source_tier": "company_owned",
          "summary": "This Cencora FY24 Corporate Responsibility Reporting Index provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The report details robust governance structures, including named committees and officers, operational risk assessments, and a Code of Ethics review process, demonstrating strong oversight. It also highlights external accountability through third-party assurance procedures and privacy protections via certifications and vetting of business partners, while AI use cases are mentioned, contributing to transparency.",
          "title": "Cencora FY24 Corporate Responsibility Reporting Index",
          "url": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-reporting-index-v8-remediated.pdf"
        },
        {
          "artifact_type": "sec_filing",
          "source_id": "src_011",
          "source_tier": "third_party",
          "summary": "This Form 10-K filing provides evidence for **governance**, **oversight**, **privacy**, and **external accountability**. It details Cencora's cybersecurity governance structure with CISO/CDIO roles and Board oversight through Audit and Compliance & Risk Committees, supporting **governance** and **oversight**. The report also mentions a vendor risk management program and internal controls over financial reporting, contributing to **governance** and **external accountability**. Furthermore, the description of a security program and annual reviews by the CISO and third parties supports the **privacy** pillar.",
          "title": "Form 10-K: Cencora, Inc. FY2024",
          "url": "https://s203.q4cdn.com/785768684/files/doc_financials/2024/q4/ba288052-12c4-42c5-84ce-7fb924e30f65.pdf"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_012",
          "source_tier": "company_owned",
          "summary": "This press release from Cencora provides evidence for the **governance** and **privacy** pillars. It supports governance by detailing the company's proactive response to a data security incident, including the engagement of cybersecurity experts and the reinforcement of security protocols. The document also supports the privacy pillar by documenting measures taken to address unauthorized data exfiltration, implying a focus on data protection.",
          "title": "Notice of Data Security Incident - Cencora",
          "url": "https://cencora.com/caredx-notice"
        },
        {
          "artifact_type": "technical_paper",
          "source_id": "src_014",
          "source_tier": "third_party",
          "summary": "This technical paper, \"Artificial Intelligence at Cencora,\" provides evidence for the **governance** and **transparency** pillars of responsible AI. The document supports transparency by detailing specific AI capabilities, use cases like NLP-based benefit verification and predictive analytics for medication adherence, and the underlying algorithms and training approaches. Evidence for governance is found in the description of data use for decision-making and resource allocation, as well as mentions of \"Best Practices\" and \"guides\" related to AI application.",
          "title": "Artificial Intelligence at Cencora",
          "url": "https://emerj.com/artificial-intelligence-at-cencora"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_015",
          "source_tier": "third_party",
          "summary": "This Cencora Inc. Definitive Proxy Statement 2026 provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. The document details board and committee structures responsible for risk oversight, including cybersecurity and enterprise risk management, demonstrating robust governance and oversight mechanisms. It also highlights processes for shareholder feedback and the adoption of policies like compensation recoupment, which support external accountability and compliance. Furthermore, the proxy statement touches upon data governance and responsible technology integration, including AI, and mentions privacy considerations within disclosure policies, supporting the privacy pillar.",
          "title": "Cencora Inc. Definitive Proxy Statement 2026",
          "url": "https://stocktitan.net/sec-filings/COR/def-14a-cencora-inc-definitive-proxy-statement-a4215304321a.html"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_016",
          "source_tier": "company_owned",
          "summary": "This company-owned charter, the \"Code of Ethics and Business Conduct,\" provides evidence for **governance**, **external accountability**, and **privacy**. It supports governance through its comprehensive framework for fraud prevention, conflict of interest, and corruption, overseen by a Chief Compliance Officer with established review and approval processes. The charter also demonstrates external accountability by outlining compliance attestations and disciplinary actions, while privacy is addressed through specific reporting mechanisms for privacy incidents.",
          "title": "Code of Ethics and Business Conduct",
          "url": "https://investor.cencora.com/files/doc_downloads/2024/02/English_2023-2024-Code-of-Ethics.pdf"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_018",
          "source_tier": "third_party",
          "summary": "This committee charter provides evidence for the governance, oversight, and privacy pillars of responsible AI. It demonstrates governance and oversight by outlining the committee's role in overseeing enterprise risk management, compliance programs, and the implementation of necessary policies and risk programs. The charter also supports privacy oversight through its mention of quarterly reports covering data protection.",
          "title": "Compliance and Risk Committee Charter",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/committees_documents/2023/Compliance-and-Risk-Committee-Charter-vF.pdf"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_019",
          "source_tier": "third_party",
          "summary": "The \"Cencora Governance Principles\" charter provides evidence for the **governance** pillar. This document establishes a board governance framework that outlines principles for asset protection through accounting controls, major risk assessment and mitigation, and financial integrity, thereby demonstrating a policy commitment to responsible oversight.",
          "title": "Cencora Governance Principles",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/2023/11/Cencora-Governance-Principles-vF.pdf"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_020",
          "source_tier": "third_party",
          "summary": "This proxy statement provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. It details mechanisms for board and committee oversight of enterprise risk management, financial reporting, and compliance, supporting governance and oversight. The document also highlights the role of the Audit Committee in managing auditor independence and internal controls, which demonstrates external accountability. Furthermore, it mentions senior leadership and committees reporting on data governance and security risks, indicating support for the privacy pillar.",
          "title": "2026 Proxy Statement & Shareholder Letter",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/2025/ba55fb6b-8baa-41b5-a467-e2fb086c7c43.pdf"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_022",
          "source_tier": "company_owned",
          "summary": "This press release on AI in pharmacovigilance provides evidence for **external accountability, governance, and oversight**. It highlights the importance of compliance, guardrails, and validation for AI systems, demonstrating a commitment to regulatory expectations and audit-friendliness, which supports external accountability and governance. Furthermore, the emphasis on human-in-the-loop involvement and data standardization before AI adoption points to robust oversight and governance mechanisms.",
          "title": "The growing case for AI to support pharmacovigilance",
          "url": "https://cencora.com/resources/pharma/world-drug-safety-congress-americas-key-takeaways"
        },
        {
          "artifact_type": "other",
          "source_id": "src_023",
          "source_tier": "company_owned",
          "summary": "This company-owned description of Cencora's pharmacovigilance services provides evidence for the **governance** and **privacy** pillars. It supports governance by mentioning practices related to governance, risk management, data management, and quality assurance. For privacy, the document supports the pillar by referencing a commitment to using secure technologies.",
          "title": "Patient Safety - Global Pharmacovigilance Solutions",
          "url": "https://cencora.com/our-capabilities/commercialization-support/patient-safety"
        },
        {
          "artifact_type": "other",
          "source_id": "src_024",
          "source_tier": "company_owned",
          "summary": "The \"Quality Management & Compliance Services\" document provides evidence for **external accountability** and **governance**. It supports external accountability by mentioning an \"audit trail\" functionality, which implies a record of actions for external scrutiny. The document also supports governance through references to \"quality assurance systems,\" \"risk management strategies,\" \"remediation plans,\" and \"training programs,\" all of which indicate structured processes and accountability for managing product lifecycle and compliance.",
          "title": "Quality Management & Compliance Services",
          "url": "https://cencora.com/our-capabilities/commercialization-support/quality-management-and-compliance"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_026",
          "source_tier": "company_owned",
          "summary": "This press release provides evidence for the **governance**, **privacy**, and **external_accountability** pillars. It supports **privacy** and **external_accountability** by highlighting commitments to data protection, third-party vetting, and certifications. **Governance** is implied through the mention of corporate responsibility governance structures and program leadership.",
          "title": "Environmental, Social, and Governance Summary Report",
          "url": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-crsummaryreport-fnl.pdf"
        },
        {
          "artifact_type": "privacy_policy",
          "source_id": "src_027",
          "source_tier": "company_owned",
          "summary": "This \"State Supplement to Privacy Statement\" provides evidence for the **governance**, **oversight**, and **privacy** pillars. The document supports these pillars by outlining user rights such as data access, deletion, and the ability to appeal decisions on data requests, demonstrating oversight and accountability. It also details data usage for various purposes including marketing and security, and describes mechanisms for opting out of targeted advertising and sensitive data processing, reflecting established privacy controls and governance policies.",
          "title": "State Supplement to Privacy Statement",
          "url": "https://cencora.com/global-supplement"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_028",
          "source_tier": "company_owned",
          "summary": "This press release discusses the integration of statistics with AI in the biopharma industry, providing evidence for **governance**, **transparency**, and **fairness**. The document suggests governance over AI's lifecycle and its use in regulatory decisions, as well as transparency in AI's application for pattern discovery and subgroup identification. Furthermore, it addresses bias by implying a principled, data-adaptive approach for AI in trials, supporting the fairness pillar.",
          "title": "RISW 2025 Takeaways: Workshop sheds light on important statistical advances for the biopharma industry",
          "url": "https://www.cencora.com/resources/pharma/2025-risw-workshop-takeaways"
        }
      ],
      "score": 2,
      "source_count": 23
    },
    "oversight": {
      "best_evidence_type": "POLICY",
      "display_name": "Human Oversight & Accountability",
      "evidence_count": 34,
      "findings": "Documentation emphasizes human-led governance, human oversight, vendor oversight, and contractual safeguards for AI deployment. System cards mention human oversight with user override capabilities and operational practices like annual audits and risk reviews. Board and committee oversight mechanisms are detailed for enterprise risk management, compliance programs, and financial reporting, including quarterly reports covering data protection.",
      "max_score": 2,
      "path_to_improvement": "Publish override mechanisms, escalation processes, or appeal workflows.",
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_003",
          "source_tier": "company_owned",
          "summary": "This press release on Project ELSA provides evidence for the **external_accountability**, **governance**, **oversight**, **privacy**, and **transparency** pillars. It supports these by emphasizing human-led governance, vendor oversight, contractual safeguards, and a risk-based approach to AI deployment. The document highlights the importance of human oversight, data protection, privacy governance, transparency regarding AI capabilities and limitations, and FDA acknowledgment of these principles as foundational tenets for responsible AI use.",
          "title": "What Project ELSA means for the FDA's approach to AI",
          "url": "https://cencora.com/resources/pharma/what-project-elsa-means-for-the-fdas-approach-to-ai"
        },
        {
          "artifact_type": "system_card",
          "source_id": "src_004",
          "source_tier": "company_owned",
          "summary": "This system card, \"AI-Assistance in TMF Privacy & Data Protection Statement,\" provides evidence for **external_accountability, governance, oversight, privacy, and transparency**. It supports these pillars by describing the AI system's capabilities and use case, its alignment with governance frameworks, and its low-risk classification. Furthermore, the document details privacy safeguards, including Data Protection Impact Assessments (DPIAs) and Records of Processing Activities (RoPA), and mentions human oversight with user override capabilities, alongside operational practices like annual audits and risk reviews.",
          "title": "AI-Assistance in TMF Privacy & Data Protection Statement",
          "url": "https://www.cencora.com/our-capabilities/drug-research-and-clinical-development-support/tmf-software-and-services/ai-privacy-and-data-protection-assurance-statement"
        },
        {
          "artifact_type": "sec_filing",
          "source_id": "src_011",
          "source_tier": "third_party",
          "summary": "This Form 10-K filing provides evidence for **governance**, **oversight**, **privacy**, and **external accountability**. It details Cencora's cybersecurity governance structure with CISO/CDIO roles and Board oversight through Audit and Compliance & Risk Committees, supporting **governance** and **oversight**. The report also mentions a vendor risk management program and internal controls over financial reporting, contributing to **governance** and **external accountability**. Furthermore, the description of a security program and annual reviews by the CISO and third parties supports the **privacy** pillar.",
          "title": "Form 10-K: Cencora, Inc. FY2024",
          "url": "https://s203.q4cdn.com/785768684/files/doc_financials/2024/q4/ba288052-12c4-42c5-84ce-7fb924e30f65.pdf"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_015",
          "source_tier": "third_party",
          "summary": "This Cencora Inc. Definitive Proxy Statement 2026 provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. The document details board and committee structures responsible for risk oversight, including cybersecurity and enterprise risk management, demonstrating robust governance and oversight mechanisms. It also highlights processes for shareholder feedback and the adoption of policies like compensation recoupment, which support external accountability and compliance. Furthermore, the proxy statement touches upon data governance and responsible technology integration, including AI, and mentions privacy considerations within disclosure policies, supporting the privacy pillar.",
          "title": "Cencora Inc. Definitive Proxy Statement 2026",
          "url": "https://stocktitan.net/sec-filings/COR/def-14a-cencora-inc-definitive-proxy-statement-a4215304321a.html"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_018",
          "source_tier": "third_party",
          "summary": "This committee charter provides evidence for the governance, oversight, and privacy pillars of responsible AI. It demonstrates governance and oversight by outlining the committee's role in overseeing enterprise risk management, compliance programs, and the implementation of necessary policies and risk programs. The charter also supports privacy oversight through its mention of quarterly reports covering data protection.",
          "title": "Compliance and Risk Committee Charter",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/committees_documents/2023/Compliance-and-Risk-Committee-Charter-vF.pdf"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_020",
          "source_tier": "third_party",
          "summary": "This proxy statement provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. It details mechanisms for board and committee oversight of enterprise risk management, financial reporting, and compliance, supporting governance and oversight. The document also highlights the role of the Audit Committee in managing auditor independence and internal controls, which demonstrates external accountability. Furthermore, it mentions senior leadership and committees reporting on data governance and security risks, indicating support for the privacy pillar.",
          "title": "2026 Proxy Statement & Shareholder Letter",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/2025/ba55fb6b-8baa-41b5-a467-e2fb086c7c43.pdf"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_022",
          "source_tier": "company_owned",
          "summary": "This press release on AI in pharmacovigilance provides evidence for **external accountability, governance, and oversight**. It highlights the importance of compliance, guardrails, and validation for AI systems, demonstrating a commitment to regulatory expectations and audit-friendliness, which supports external accountability and governance. Furthermore, the emphasis on human-in-the-loop involvement and data standardization before AI adoption points to robust oversight and governance mechanisms.",
          "title": "The growing case for AI to support pharmacovigilance",
          "url": "https://cencora.com/resources/pharma/world-drug-safety-congress-americas-key-takeaways"
        },
        {
          "artifact_type": "privacy_policy",
          "source_id": "src_027",
          "source_tier": "company_owned",
          "summary": "This \"State Supplement to Privacy Statement\" provides evidence for the **governance**, **oversight**, and **privacy** pillars. The document supports these pillars by outlining user rights such as data access, deletion, and the ability to appeal decisions on data requests, demonstrating oversight and accountability. It also details data usage for various purposes including marketing and security, and describes mechanisms for opting out of targeted advertising and sensitive data processing, reflecting established privacy controls and governance policies.",
          "title": "State Supplement to Privacy Statement",
          "url": "https://cencora.com/global-supplement"
        }
      ],
      "score": 1,
      "source_count": 8
    },
    "privacy": {
      "best_evidence_type": "OPERATIONAL",
      "display_name": "Privacy & Security",
      "evidence_count": 39,
      "findings": "Privacy statements detail safeguards, access controls, protection of personal data, and consent requirements, including specific protections for children's data. Documentation highlights data protection, privacy governance, and privacy safeguards such as Data Protection Impact Assessments (DPIAs) and Records of Processing Activities (RoPA). The company references a commitment to using secure technologies, outlines user rights for data access and deletion, and describes mechanisms for opting out of targeted advertising and sensitive data processing.",
      "max_score": 2,
      "path_to_improvement": null,
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_001",
          "source_tier": "company_owned",
          "summary": "This press release discusses the role of AI in pharmaceutical innovation, providing evidence for the **governance**, **privacy**, and **transparency** pillars. It highlights the need for robust data governance frameworks and standards for AI deployment, and addresses data privacy integration challenges. The release also emphasizes the importance of transparency in AI algorithms to avoid biases and ensure accurate outcomes.",
          "title": "Pharma 2025 Insights: Harnessing AI in pharma",
          "url": "https://cencora.com/resources/pharma/insights-from-pharma-2025-harnessing-ai"
        },
        {
          "artifact_type": "privacy_policy",
          "source_id": "src_002",
          "source_tier": "company_owned",
          "summary": "The Cencora Global Privacy Statement provides evidence for the **governance** and **privacy** pillars. This policy document supports governance by outlining conditions for data disclosure and rules for data use, and it supports privacy by detailing safeguards, access controls, protection of personal data, and consent requirements, including specific protections for children's data.",
          "title": "Global Privacy Statement - Cencora",
          "url": "https://cencora.com/global-privacy-statement"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_003",
          "source_tier": "company_owned",
          "summary": "This press release on Project ELSA provides evidence for the **external_accountability**, **governance**, **oversight**, **privacy**, and **transparency** pillars. It supports these by emphasizing human-led governance, vendor oversight, contractual safeguards, and a risk-based approach to AI deployment. The document highlights the importance of human oversight, data protection, privacy governance, transparency regarding AI capabilities and limitations, and FDA acknowledgment of these principles as foundational tenets for responsible AI use.",
          "title": "What Project ELSA means for the FDA's approach to AI",
          "url": "https://cencora.com/resources/pharma/what-project-elsa-means-for-the-fdas-approach-to-ai"
        },
        {
          "artifact_type": "system_card",
          "source_id": "src_004",
          "source_tier": "company_owned",
          "summary": "This system card, \"AI-Assistance in TMF Privacy & Data Protection Statement,\" provides evidence for **external_accountability, governance, oversight, privacy, and transparency**. It supports these pillars by describing the AI system's capabilities and use case, its alignment with governance frameworks, and its low-risk classification. Furthermore, the document details privacy safeguards, including Data Protection Impact Assessments (DPIAs) and Records of Processing Activities (RoPA), and mentions human oversight with user override capabilities, alongside operational practices like annual audits and risk reviews.",
          "title": "AI-Assistance in TMF Privacy & Data Protection Statement",
          "url": "https://www.cencora.com/our-capabilities/drug-research-and-clinical-development-support/tmf-software-and-services/ai-privacy-and-data-protection-assurance-statement"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_005",
          "source_tier": "company_owned",
          "summary": "This press release discusses AI-driven formulary decision-making systems, providing narrative evidence for **governance**, **privacy**, and **transparency**. It mentions AI use cases and decision-makers' recognition, supporting governance, while also touching on security/privacy concerns to support the privacy pillar. The press release also describes the AI's role and company leadership, contributing to the transparency pillar.",
          "title": "Unlock the future of formulary decision-making with AI",
          "url": "https://cencora.com/resources/pharma/unlock-the-future-of-formulary-decision-making-with-ai"
        },
        {
          "artifact_type": "audit_report",
          "source_id": "src_010",
          "source_tier": "company_owned",
          "summary": "This Cencora FY24 Corporate Responsibility Reporting Index provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The report details robust governance structures, including named committees and officers, operational risk assessments, and a Code of Ethics review process, demonstrating strong oversight. It also highlights external accountability through third-party assurance procedures and privacy protections via certifications and vetting of business partners, while AI use cases are mentioned, contributing to transparency.",
          "title": "Cencora FY24 Corporate Responsibility Reporting Index",
          "url": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-reporting-index-v8-remediated.pdf"
        },
        {
          "artifact_type": "sec_filing",
          "source_id": "src_011",
          "source_tier": "third_party",
          "summary": "This Form 10-K filing provides evidence for **governance**, **oversight**, **privacy**, and **external accountability**. It details Cencora's cybersecurity governance structure with CISO/CDIO roles and Board oversight through Audit and Compliance & Risk Committees, supporting **governance** and **oversight**. The report also mentions a vendor risk management program and internal controls over financial reporting, contributing to **governance** and **external accountability**. Furthermore, the description of a security program and annual reviews by the CISO and third parties supports the **privacy** pillar.",
          "title": "Form 10-K: Cencora, Inc. FY2024",
          "url": "https://s203.q4cdn.com/785768684/files/doc_financials/2024/q4/ba288052-12c4-42c5-84ce-7fb924e30f65.pdf"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_012",
          "source_tier": "company_owned",
          "summary": "This press release from Cencora provides evidence for the **governance** and **privacy** pillars. It supports governance by detailing the company's proactive response to a data security incident, including the engagement of cybersecurity experts and the reinforcement of security protocols. The document also supports the privacy pillar by documenting measures taken to address unauthorized data exfiltration, implying a focus on data protection.",
          "title": "Notice of Data Security Incident - Cencora",
          "url": "https://cencora.com/caredx-notice"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_015",
          "source_tier": "third_party",
          "summary": "This Cencora Inc. Definitive Proxy Statement 2026 provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. The document details board and committee structures responsible for risk oversight, including cybersecurity and enterprise risk management, demonstrating robust governance and oversight mechanisms. It also highlights processes for shareholder feedback and the adoption of policies like compensation recoupment, which support external accountability and compliance. Furthermore, the proxy statement touches upon data governance and responsible technology integration, including AI, and mentions privacy considerations within disclosure policies, supporting the privacy pillar.",
          "title": "Cencora Inc. Definitive Proxy Statement 2026",
          "url": "https://stocktitan.net/sec-filings/COR/def-14a-cencora-inc-definitive-proxy-statement-a4215304321a.html"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_016",
          "source_tier": "company_owned",
          "summary": "This company-owned charter, the \"Code of Ethics and Business Conduct,\" provides evidence for **governance**, **external accountability**, and **privacy**. It supports governance through its comprehensive framework for fraud prevention, conflict of interest, and corruption, overseen by a Chief Compliance Officer with established review and approval processes. The charter also demonstrates external accountability by outlining compliance attestations and disciplinary actions, while privacy is addressed through specific reporting mechanisms for privacy incidents.",
          "title": "Code of Ethics and Business Conduct",
          "url": "https://investor.cencora.com/files/doc_downloads/2024/02/English_2023-2024-Code-of-Ethics.pdf"
        },
        {
          "artifact_type": "charter",
          "source_id": "src_018",
          "source_tier": "third_party",
          "summary": "This committee charter provides evidence for the governance, oversight, and privacy pillars of responsible AI. It demonstrates governance and oversight by outlining the committee's role in overseeing enterprise risk management, compliance programs, and the implementation of necessary policies and risk programs. The charter also supports privacy oversight through its mention of quarterly reports covering data protection.",
          "title": "Compliance and Risk Committee Charter",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/committees_documents/2023/Compliance-and-Risk-Committee-Charter-vF.pdf"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_020",
          "source_tier": "third_party",
          "summary": "This proxy statement provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. It details mechanisms for board and committee oversight of enterprise risk management, financial reporting, and compliance, supporting governance and oversight. The document also highlights the role of the Audit Committee in managing auditor independence and internal controls, which demonstrates external accountability. Furthermore, it mentions senior leadership and committees reporting on data governance and security risks, indicating support for the privacy pillar.",
          "title": "2026 Proxy Statement & Shareholder Letter",
          "url": "https://s203.q4cdn.com/785768684/files/doc_downloads/2025/ba55fb6b-8baa-41b5-a467-e2fb086c7c43.pdf"
        },
        {
          "artifact_type": "other",
          "source_id": "src_023",
          "source_tier": "company_owned",
          "summary": "This company-owned description of Cencora's pharmacovigilance services provides evidence for the **governance** and **privacy** pillars. It supports governance by mentioning practices related to governance, risk management, data management, and quality assurance. For privacy, the document supports the pillar by referencing a commitment to using secure technologies.",
          "title": "Patient Safety - Global Pharmacovigilance Solutions",
          "url": "https://cencora.com/our-capabilities/commercialization-support/patient-safety"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_026",
          "source_tier": "company_owned",
          "summary": "This press release provides evidence for the **governance**, **privacy**, and **external_accountability** pillars. It supports **privacy** and **external_accountability** by highlighting commitments to data protection, third-party vetting, and certifications. **Governance** is implied through the mention of corporate responsibility governance structures and program leadership.",
          "title": "Environmental, Social, and Governance Summary Report",
          "url": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-crsummaryreport-fnl.pdf"
        },
        {
          "artifact_type": "privacy_policy",
          "source_id": "src_027",
          "source_tier": "company_owned",
          "summary": "This \"State Supplement to Privacy Statement\" provides evidence for the **governance**, **oversight**, and **privacy** pillars. The document supports these pillars by outlining user rights such as data access, deletion, and the ability to appeal decisions on data requests, demonstrating oversight and accountability. It also details data usage for various purposes including marketing and security, and describes mechanisms for opting out of targeted advertising and sensitive data processing, reflecting established privacy controls and governance policies.",
          "title": "State Supplement to Privacy Statement",
          "url": "https://cencora.com/global-supplement"
        }
      ],
      "score": 2,
      "source_count": 15
    },
    "transparency": {
      "best_evidence_type": "OPERATIONAL",
      "display_name": "Transparency",
      "evidence_count": 33,
      "findings": "Documentation describes AI system capabilities, use cases, and the AI's role, including specific applications like NLP-based benefit verification and predictive analytics. Technical papers detail underlying algorithms and training approaches. Press releases emphasize the importance of transparency in AI algorithms to avoid biases, ensure accurate outcomes, and highlight AI capabilities and limitations.",
      "max_score": 2,
      "path_to_improvement": null,
      "relevant_sources": [
        {
          "artifact_type": "press_release",
          "source_id": "src_001",
          "source_tier": "company_owned",
          "summary": "This press release discusses the role of AI in pharmaceutical innovation, providing evidence for the **governance**, **privacy**, and **transparency** pillars. It highlights the need for robust data governance frameworks and standards for AI deployment, and addresses data privacy integration challenges. The release also emphasizes the importance of transparency in AI algorithms to avoid biases and ensure accurate outcomes.",
          "title": "Pharma 2025 Insights: Harnessing AI in pharma",
          "url": "https://cencora.com/resources/pharma/insights-from-pharma-2025-harnessing-ai"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_003",
          "source_tier": "company_owned",
          "summary": "This press release on Project ELSA provides evidence for the **external_accountability**, **governance**, **oversight**, **privacy**, and **transparency** pillars. It supports these by emphasizing human-led governance, vendor oversight, contractual safeguards, and a risk-based approach to AI deployment. The document highlights the importance of human oversight, data protection, privacy governance, transparency regarding AI capabilities and limitations, and FDA acknowledgment of these principles as foundational tenets for responsible AI use.",
          "title": "What Project ELSA means for the FDA's approach to AI",
          "url": "https://cencora.com/resources/pharma/what-project-elsa-means-for-the-fdas-approach-to-ai"
        },
        {
          "artifact_type": "system_card",
          "source_id": "src_004",
          "source_tier": "company_owned",
          "summary": "This system card, \"AI-Assistance in TMF Privacy & Data Protection Statement,\" provides evidence for **external_accountability, governance, oversight, privacy, and transparency**. It supports these pillars by describing the AI system's capabilities and use case, its alignment with governance frameworks, and its low-risk classification. Furthermore, the document details privacy safeguards, including Data Protection Impact Assessments (DPIAs) and Records of Processing Activities (RoPA), and mentions human oversight with user override capabilities, alongside operational practices like annual audits and risk reviews.",
          "title": "AI-Assistance in TMF Privacy & Data Protection Statement",
          "url": "https://www.cencora.com/our-capabilities/drug-research-and-clinical-development-support/tmf-software-and-services/ai-privacy-and-data-protection-assurance-statement"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_005",
          "source_tier": "company_owned",
          "summary": "This press release discusses AI-driven formulary decision-making systems, providing narrative evidence for **governance**, **privacy**, and **transparency**. It mentions AI use cases and decision-makers' recognition, supporting governance, while also touching on security/privacy concerns to support the privacy pillar. The press release also describes the AI's role and company leadership, contributing to the transparency pillar.",
          "title": "Unlock the future of formulary decision-making with AI",
          "url": "https://cencora.com/resources/pharma/unlock-the-future-of-formulary-decision-making-with-ai"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_006",
          "source_tier": "company_owned",
          "summary": "This press release, \"Data governance and AI in pharma,\" provides evidence for the **governance** and **transparency** pillars of responsible AI. It supports governance by discussing data governance strategies and AI compliance, implying a commitment to managing AI responsibly, though without specific execution details. The press release also touches on transparency by mentioning AI use cases and how AI is transforming operations, indicating an aspirational discovery of AI capabilities.",
          "title": "Data governance and AI in pharma",
          "url": "https://cencora.com/resources/pharma/data-governance-and-ai-in-pharma"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_007",
          "source_tier": "company_owned",
          "summary": "This company-owned press release discusses the utilization of real-world evidence to support market access decisions, touching upon responsible AI. It provides evidence for **fairness** by acknowledging the need to address bias in digital tools. The press release also supports **governance** by discussing data use and regulatory comfortability, though it focuses on challenges and future needs rather than current execution. Finally, it offers evidence for **transparency** by describing the value of AI-driven insights and data generation capabilities.",
          "title": "Leveraging real-world evidence to support market access decision-making",
          "url": "https://cencora.com/resources/pharma/leveraging-rwe-to-support-market-access-decision-making"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_008",
          "source_tier": "company_owned",
          "summary": "This press release discusses the application of AI and advanced analytics in pharmacovigilance signal management, providing evidence for **governance** and **transparency**. The document implies governance by mentioning a Head of Pharmacovigilance and their area of responsibility, suggesting oversight of AI applications in this domain. It also supports transparency by describing AI capabilities and use cases in transforming pharmacovigilance, though it focuses on impact rather than specific operational execution.",
          "title": "Harnessing AI and advanced analytics to revolutionize PV signal management",
          "url": "https://cencora.com/resources/pharma/harnessing-ai-and-advanced-analytics-to-revolutionize-pv-signal-management"
        },
        {
          "artifact_type": "audit_report",
          "source_id": "src_010",
          "source_tier": "company_owned",
          "summary": "This Cencora FY24 Corporate Responsibility Reporting Index provides evidence for **governance**, **external accountability**, **privacy**, and **transparency**. The report details robust governance structures, including named committees and officers, operational risk assessments, and a Code of Ethics review process, demonstrating strong oversight. It also highlights external accountability through third-party assurance procedures and privacy protections via certifications and vetting of business partners, while AI use cases are mentioned, contributing to transparency.",
          "title": "Cencora FY24 Corporate Responsibility Reporting Index",
          "url": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-reporting-index-v8-remediated.pdf"
        },
        {
          "artifact_type": "technical_paper",
          "source_id": "src_014",
          "source_tier": "third_party",
          "summary": "This technical paper, \"Artificial Intelligence at Cencora,\" provides evidence for the **governance** and **transparency** pillars of responsible AI. The document supports transparency by detailing specific AI capabilities, use cases like NLP-based benefit verification and predictive analytics for medication adherence, and the underlying algorithms and training approaches. Evidence for governance is found in the description of data use for decision-making and resource allocation, as well as mentions of \"Best Practices\" and \"guides\" related to AI application.",
          "title": "Artificial Intelligence at Cencora",
          "url": "https://emerj.com/artificial-intelligence-at-cencora"
        },
        {
          "artifact_type": "proxy_statement",
          "source_id": "src_015",
          "source_tier": "third_party",
          "summary": "This Cencora Inc. Definitive Proxy Statement 2026 provides evidence for **governance**, **oversight**, **external accountability**, and **privacy**. The document details board and committee structures responsible for risk oversight, including cybersecurity and enterprise risk management, demonstrating robust governance and oversight mechanisms. It also highlights processes for shareholder feedback and the adoption of policies like compensation recoupment, which support external accountability and compliance. Furthermore, the proxy statement touches upon data governance and responsible technology integration, including AI, and mentions privacy considerations within disclosure policies, supporting the privacy pillar.",
          "title": "Cencora Inc. Definitive Proxy Statement 2026",
          "url": "https://stocktitan.net/sec-filings/COR/def-14a-cencora-inc-definitive-proxy-statement-a4215304321a.html"
        },
        {
          "artifact_type": "press_release",
          "source_id": "src_028",
          "source_tier": "company_owned",
          "summary": "This press release discusses the integration of statistics with AI in the biopharma industry, providing evidence for **governance**, **transparency**, and **fairness**. The document suggests governance over AI's lifecycle and its use in regulatory decisions, as well as transparency in AI's application for pattern discovery and subgroup identification. Furthermore, it addresses bias by implying a principled, data-adaptive approach for AI in trials, supporting the fairness pillar.",
          "title": "RISW 2025 Takeaways: Workshop sheds light on important statistical advances for the biopharma industry",
          "url": "https://www.cencora.com/resources/pharma/2025-risw-workshop-takeaways"
        }
      ],
      "score": 2,
      "source_count": 11
    }
  },
  "published_at": "2026-02-23T21:46:22Z",
  "run_id": "20260124_003353_cfa5",
  "schema_version": "1.0",
  "summary": {
    "key_gaps": [
      "Explainability"
    ],
    "key_strengths": [
      "Transparency",
      "Privacy & Security",
      "Governance & Accountability",
      "Public Commitments & External Audits"
    ],
    "overall_findings": "Cencora's Global Privacy Statements detail safeguards, access controls, and consent requirements for personal data, including specific protections for children's data. These materials, along with press releases emphasizing human-led governance and vendor oversight, document 6 of 7 evaluated responsible AI pillars. Fairness and oversight are addressed through policies, with disclosures acknowledging the need to address bias in digital tools and highlighting the importance of human oversight. No qualifying public evidence was found for explainability. This assessment draws on 28 publicly available sources.",
    "pillars_operational": 4,
    "pillars_policy_only": 2,
    "pillars_with_evidence": 6,
    "pillars_without_evidence": 1,
    "total_evidence_items": 214,
    "total_sources_used": 23
  }
}
